Integrating Multimodal MRI Habitat and Transformer‐Based Pathomics to Predict High‐Risk Molecular Subtypes and Explore Biological Mechanisms in Adult Diffuse Gliomas
This study aims to achieve accurate prediction of high‐risk molecular subtypes of gliomas through a cross‐scale Combined model, matching the model's classification metrics with patient risk stratification and exploring the underlying biological mechanisms.
The conceptual landscape of clinical oncology and cancer biology has undergone a profound transformation in recent decades, evolving from static anatomical staging and broad histopathological classification into a dynamic, molecularly stratified discipline [...].
Chia-Ching Chen, Hsin-Hung Chen, Po-Ming Chen· Current Issues in Molecular...· 0 citations
Highlights • Plasma GFAP and NfL show strong individual accuracy for GBM detection.• A multivariate six-biomarker model achieves near-perfect GBM discrimination.• The model shows high sensitivity for distinguishing GBM from healthy controls but requires validation in symptomatic non-GBM cohorts before clinical rule-out...
J. Decarpentrie, C. David, N. Donis et al.· Translational Oncology· 0 citations
, recurrence, treatment response, and treatment-related risks. Several studies also illustrate a broader shift toward automation, multimodal data fusion, and clinically scalable arti fi cial intelligence (AI) pipelines, including applications to histological images and the integration of histopathology with RNA sequenci...
Arka Bhowmik, Sunitha B. Thakur, A. Bitencourt et al.· Frontiers in Oncology· 0 citations
Existing deep learning models for predicting biochemical recurrence (BCR) after radical prostatectomy often ignore the biological context beyond the tumor. This study aims to develop and validate a transformer‐based model combining multi‐regional magnetic resonance imaging (MRI) features and clinical data to improve BC...
Meng-Ting Zhou, K. Lu, Yu-Hua Liu et al.· Cancer Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.